Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LSNE continues their expansion with the addition of increased cGMP storage capabilities at its 7 Commerce Drive facility located in Bedford, New Hampshire.
read more
Lyophilization Services of New England has acquired PSC Biotech’s cGMP aseptic fill finish manufacturing facility located in Madison, Wisconsin
read more
Tuesday, November 18, 2025
LSL Pharma Group has completed the acquisition of Laboratoire Du-Var Inc. a contract manufacturer of cosmetics and natural health products established in 1947.
read more
Lotus Clinical Research has announced the addition of Lee Simon, MD, FACP, FACR as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD, JD as Medical Imaging and Research Advisor.
read more
Bristol Myers Squibb and LOTTE Corporation announced that LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New York.
read more
LOTTE BIOLOGICS announced that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing first-in-class, one-of-a-kind PD1/VEGFR2 dual pathway antibodies to extend the lives ...
read more
LOTTE Biologics announced an expansion of its collaboration with Ottimo Pharma, a biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies.
read more
LOTTE BIOLOGICS announced that it has signed a manufacturing agreement with an Asia-based biotech company for the production of a clinical-stage ADC candidate.
read more
Losan Pharma will introduce the latest version of Werum’s PAS-X MES at its main facility in Neuenburg am Rhein, Germany.
read more
Monday, December 21, 2020
Lonza and the VMIC announced a project to implement the MODA-EM Solution to automate QC in the new facility.
read more
Monday, December 05, 2022
Lonza announced the start of new mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
read more
Lonza Sanquin Reagents have entered into a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test.
read more
Wednesday, January 19, 2022
Forbion, BioGeneration Ventures and Lonza announced the extension of their collaboration to include the development and manufacturing of small molecules.
read more
Wednesday, April 03, 2019
Chr. Hansen Holding A/S and Lonza have signed an agreement to establish a 50/50 joint venture to develop the live biotherapeutic products (LBPs) industry.
read more
Lonza and CELLINK have partnered to offer a 3D bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.
read more